Gotowa bibliografia na temat „Diagnosis/Therapy”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Diagnosis/Therapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Diagnosis/Therapy"

1

Adamski, Adam. "Diagnosis and Therapy of an Autistic Child". Biomedical Research and Clinical Reviews 3, nr 5 (19.04.2021): 01–11. http://dx.doi.org/10.31579/2692-9406/045.

Pełny tekst źródła
Streszczenie:
Knowledge of autism is growing tremendously, since the first formulation of the phenomenon of autism in 1943, there is still no cure for the cure of changes in the brain that create the symptoms of autism. I still find better ways of understanding the disease and help patients adapt, but does not give a full understanding of what autism. There are different types of therapy in the field of speech, behavior, vision, hearing, as well as drugs and dietary recommendations, but they are often ineffective. Treatments should be tailored to the individual needs of the patient. The author of that work will pay attention to corrective therapy movement, and the mechanism of imitation, these two factors in autism do not exhibit synchronization, because the child did not received during the birth. Autistic children from the area have movement disorders, and the lack of a mechanism to follow. My research results confirm the view that the movement disorder and the mechanism of imitation are inherent in the phenomenon of autism. The study of movement disorders in children, and the mechanism of imitation, may serve as an early indicator of autism diagnosis methods. They point to the need for the development of therapies to be used from the first months of life in autism.
Style APA, Harvard, Vancouver, ISO itp.
2

Sonnenberg, Amnon. "Therapy Without Diagnosis". American Journal of Gastroenterology 109, nr 11 (listopad 2014): 1837–38. http://dx.doi.org/10.1038/ajg.2014.291.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

BERNAYS, ME. "Diagnosis and therapy". Australian Veterinary Journal 76, nr 5 (maj 1998): 316. http://dx.doi.org/10.1111/j.1751-0813.1998.tb12352.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

SMITH, JS. "Diagnosis and therapy." Australian Veterinary Journal 77, nr 9 (wrzesień 1999): 566. http://dx.doi.org/10.1111/j.1751-0813.1999.tb13189.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Zimny, Nancy J., Catherine C. Goodman i Marianne Orest. "Physical Therapy Diagnosis". Physical Therapy 75, nr 7 (1.07.1995): 635–38. http://dx.doi.org/10.1093/ptj/75.7.635.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Branch, Lionel Andrew. "Timely therapy requires timely diagnosis; high risk therapy demands accurate diagnosis". Journal of the Neurological Sciences 382 (listopad 2017): 155–56. http://dx.doi.org/10.1016/j.jns.2017.07.023.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bortelová, Karolína. "Vitiligo: diagnosis and therapy". Dermatologie pro praxi 13, nr 2 (10.06.2019): 72–75. http://dx.doi.org/10.36290/der.2019.011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Yunusovа, E. I. "Keratoacanthoma: clinic, diagnosis, therapy". Dalʹnevostočnyj medicinskij žurnal, nr 2 (25.06.2021): 78–81. http://dx.doi.org/10.35177/1994-5191-2021-2-78-81.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Williamson, R. Anthony. "Prions: conformations, diagnosis, therapy". Biochemical Society Transactions 30, nr 3 (1.06.2002): A67. http://dx.doi.org/10.1042/bst030a067c.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Moore, Patricia. "Vasculitis: Diagnosis and Therapy". Seminars in Neurology 14, nr 02 (czerwiec 1994): 159–67. http://dx.doi.org/10.1055/s-2008-1041074.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Rozprawy doktorskie na temat "Diagnosis/Therapy"

1

Enomoto, Dorathy Ngauwlieng Hendrikje. "Scleroderma: diagnosis and experimental therapy". [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/57061.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Marti, Pamela. "New perspectives for allergy diagnosis and therapy /". [S.l.] : [s.n.], 2005. http://www.zb.unibe.ch/download/eldiss/06marti_p.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jolley, Clive Joseph. "Radiolabelling of antibodies for tumour diagnosis and therapy". Thesis, University of Kent, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334038.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

May, Stephen J. "Development of aspects of mechanical diagnosis and therapy". Thesis, Sheffield Hallam University, 2009. http://shura.shu.ac.uk/20757/.

Pełny tekst źródła
Streszczenie:
Mechanical Diagnosis and Therapy is a system of classification, assessment and management applied to all musculoskeletal problems that is used by clinicians worldwide. The first section concerns the up-dating and contextualising of Mechanical Diagnosis and Therapy (MDT). The books, co-authored with the founder of MDT, Robin McKenzie, applied the principles to extremity musculoskeletal problems, and then set MDT in the contemporary evidence-based background for lumbar, cervical and thoracic problems. This involved an up-dating of the classification system, as well as synthesis and analysis of aspects of musculoskeletal medicine. The second section presents a patient perspective on musculoskeletal problems. This involves an exploration of patient opinions about back pain and its management, and an audit of outcomes in a clinical setting in which an active exercise-based treatment approach was applied. The third section relates to a number of publications that sought to validate aspects of MDT. Centralisation is a key finding during the assessment of spinal patients and work on this included a systematic review of the relevant literature and an analysis of centralisation in patients with sciatica. In another study we conducted a secondary analysis of a published trial to see what happened if patients were crossed-over from exercises that were unmatched with directional preference to matched exercises. We published a case-control study that validates the postural syndrome and measured the prevalence rates of MDT classifications in the patient population. Reliability is a keycomponent of any musculoskeletal assessment system in which clinicians are making management decisions based on physical examination procedures - a systematic review that detailed the reliability of MDT compared to other commonly used examination procedures was an important contribution to the literature. Overall these works have led to a significant independent and original contribution to knowledge and understanding of MDT.
Style APA, Harvard, Vancouver, ISO itp.
5

Tse, Tsz Ho. "Medical robots for MRI guided diagnosis and therapy". Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/5643.

Pełny tekst źródła
Streszczenie:
Magnetic Resonance Imaging (MRI) provides the capability of imaging tissue with fine resolution and superior soft tissue contrast, when compared with conventional ultrasound and CT imaging, which makes it an important tool for clinicians to perform more accurate diagnosis and image guided therapy. Medical robotic devices combining the high resolution anatomical images with real-time navigation, are ideal for precise and repeatable interventions. Despite these advantages, the MR environment imposes constraints on mechatronic devices operating within it. This thesis presents a study on the design and development of robotic systems for particular MR interventions, in which the issue of testing the MR compatibility of mechatronic components, actuation control, kinematics and workspace analysis, and mechanical and electrical design of the robot have been investigated. Two types of robotic systems have therefore been developed and evaluated along the above aspects. (i) A device for MR guided transrectal prostate biopsy: The system was designed from components which are proven to be MR compatible, actuated by pneumatic motors and ultrasonic motors, and tracked by optical position sensors and ducial markers. Clinical trials have been performed with the device on three patients, and the results reported have demonstrated its capability to perform needle positioning under MR guidance, with a procedure time of around 40mins and with no compromised image quality, which achieved our system speci cations. (ii) Limb positioning devices to facilitate the magic angle effect for diagnosis of tendinous injuries: Two systems were designed particularly for lower and upper limb positioning, which are actuated and tracked by the similar methods as the first device. A group of volunteers were recruited to conduct tests to verify the functionality of the systems. The results demonstrate the clear enhancement of the image quality with an increase in signal intensity up to 24 times in the tendon tissue caused by the magic angle effect, showing the feasibility of the proposed devices to be applied in clinical diagnosis.
Style APA, Harvard, Vancouver, ISO itp.
6

COX, ALYSIA SARAH-MARIE. "Nanoparticles for Therapy and Diagnosis of Neurodegenerative Diseases". Doctoral thesis, Università degli Studi di Milano-Bicocca, 2019. http://hdl.handle.net/10281/241331.

Pełny tekst źródła
Streszczenie:
Nanoparticles (NPs) are studied as a promising tool to efficiently deliver drugs across biological barriers, which can hinder effective pharmacological treatment for a variety of diseases. One of the key issues to evaluate is the corona, a layer of proteins attached to the surface, formed upon contact of NPs with biological fluids. It is well known that the corona affects bioavailability, toxicity and clearance of NPs. Though the corona is relatively well defined under various conditions, its evolution when it crosses biological barriers was unknown. In my research I utilized gold NPs and a transwell cellular model of the BBB (human brain endothelial cells - hCMEC/D3) to investigate this issue. The protein composition of the corona across the “brain” and “blood” compartments was qualitatively and semi-quantitatively analyzed using SDS-PAGE and MS. The protein corona changed dramatically following passage through the BBB, since many proteins were removed, and 15 out of 381 were enriched in the “brain” side compared to the “blood” side, including alpha-2-macroglobulin and fetuin A. This clearly indicates the dynamic nature of the corona, and the ability or inability of specific proteins bound to NPs to traverse the BBB. The research also established that NP corona in the basolateral side is actually an evolution of the one formed on the apical side ruling out that it is formed in situ by interaction with proteins arriving independently from the apical side. Once beyond the barrier, the corona was stable upon incubation with other proteins Proteins that were enriched upon passage were used to functionalize NPs, demonstrating their ability to boost passage through the BBB and suggesting that physiological proteins could help to more effectively deliver drugs to the central nervous system. Altogether, these results are particularly relevant when developing NPs that are required to traverse any biological barrier and may lead to the more successful design of therapeutic and/or diagnostic nanodevices.
Nanoparticles (NPs) are studied as a promising tool to efficiently deliver drugs across biological barriers, which can hinder effective pharmacological treatment for a variety of diseases. One of the key issues to evaluate is the corona, a layer of proteins attached to the surface, formed upon contact of NPs with biological fluids. It is well known that the corona affects bioavailability, toxicity and clearance of NPs. Though the corona is relatively well defined under various conditions, its evolution when it crosses biological barriers was unknown. In my research I utilized gold NPs and a transwell cellular model of the BBB (human brain endothelial cells - hCMEC/D3) to investigate this issue. The protein composition of the corona across the “brain” and “blood” compartments was qualitatively and semi-quantitatively analyzed using SDS-PAGE and MS. The protein corona changed dramatically following passage through the BBB, since many proteins were removed, and 15 out of 381 were enriched in the “brain” side compared to the “blood” side, including alpha-2-macroglobulin and fetuin A. This clearly indicates the dynamic nature of the corona, and the ability or inability of specific proteins bound to NPs to traverse the BBB. The research also established that NP corona in the basolateral side is actually an evolution of the one formed on the apical side ruling out that it is formed in situ by interaction with proteins arriving independently from the apical side. Once beyond the barrier, the corona was stable upon incubation with other proteins Proteins that were enriched upon passage were used to functionalize NPs, demonstrating their ability to boost passage through the BBB and suggesting that physiological proteins could help to more effectively deliver drugs to the central nervous system. Altogether, these results are particularly relevant when developing NPs that are required to traverse any biological barrier and may lead to the more successful design of therapeutic and/or diagnostic nanodevices.
Style APA, Harvard, Vancouver, ISO itp.
7

Sulé-Suso, Josep. "Autologous cell approaches to diagnosis and therapy in oncology". Thesis, Keele University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.252570.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Baillie-Hamilton, Paula. "Applications of magnetic resonance in cancer diagnosis and therapy". Thesis, University of Oxford, 1995. http://ora.ox.ac.uk/objects/uuid:72d25d7c-4f5a-4bc4-9fb0-45f758c09d7b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wang, Xueli. "Organic molecules for diagnosis and therapy of Alzheimer's disease". HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/883.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease has become one of the most common diseases jeopardizing the health of the human being. The main pathological feature of AD is the accumulation of Aβ in the brain to form senile plaques. Therefore, it is of great significance to develop new and efficient drugs targeting at amyloid-β for the detection, diagnosis and therapeutics for Alzheimer's disease. Xanthohumol (Xn) naturally presents in hops (Humulus lupulus L). Studies have shown that it has anti-lipoperoxidative, anti-inflammatory, anti-proliferative activities, antiangiogenic and antioxidant effects, which further illustrates its potential therapeutic for AD. However, the bio-incompatibility and blood-brain barrier impermeability of Xanthohumol hindered it in vivo efficacy potential for treating Alzheimer's disease. Thus, we designed and prepared a series of Xanthohumol derivatives, namely, Xn-n, (n = 1-9) and its chalcone derivatives C-n, (n = 1-10) to enhance the desirable physical, biological and pharmacological properties, especially the blood-brain barrier permeability for intervention of AD. As an effective technique for in vivo visualization, Near-infrared fluorescence imaging based on organic small molecule probes has a promising application in the diagnosis of Alzheimer's disease. However, most of the reported imaging probes can only visualize Aβ-plaques but do not have therapeutic potential such as neuroprotection against Aβ induced toxicity. Herein, we designed and synthesized a series of oligomeric Aβ targeted near infrared (NIR) fluorescent probes for the diagnosis and therapeutics of Alzheimer's disease, namely DBAN-SLM, DBAN-SLOH, DBAN-OSLM which showed remarkably effective inhibitory effect on Aβ aggregation, significant neuroprotection effect against the Aβ-induced toxicities, and suppression on Aβ-induced ROS generation. indicating its great promise as a useful theragnostic agent for the early diagnosis and therapy of AD. Dual-modal imaging is an important approach to overcome the limitations of single imaging technology in the diagnosis of AD disease. Therefore, based on the dual-modal, we designed and synthesized the NIR/MR dual-modal detection and theragnostic probes namely Dyad-1, Dyad-2, Dyad-3 and NP@SiO2@F-SLOH. More surprising is that the two NIR/MR dual-modal probes show excellent biological properties, including the ability to inhibit Aβ aggregation to a certain extent, neuroprotective effects on cytotoxicity caused by different forms of Aβ species, blood-brain barrier (BBB) permeability, and high stability. All of these newly designed and synthesized molecules were characterized with 1H NMR, 13C NMR, and HRMS and found to show good agreement with the desired structures. The photophysical properties and biological properties of these novel designed and synthesized fluorescent probe such as UV-vis absorption, fluorescence emission, dissociation constant determined by fluorescence titration, cytotoxicity assay, neuroprotection, and inhibition of Aβ aggregation were investigated
Style APA, Harvard, Vancouver, ISO itp.
10

Hembury, Mathew Thomas. "Gold-silica quantum rattles for cancer therapy and diagnosis". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/14493.

Pełny tekst źródła
Streszczenie:
The Holy Grail of cancer research is to find effective treatments that can be easily delivered to diseased cells with minimal collateral damage to healthy tissue. In this context, recent developments in nanoparticle technology have aroused considerable interest with the promise of multifunctional vectors for both diagnostic and treatment of cancer. Recently, new emphasis has been placed on hybrid nanoparticle (NP) systems, where combinations of different types of nanostructured materials are used to create multimodal systems that exhibit the combined beneficial properties of the component modules. In particular, nanorattles, which are NPs with a core-shell structure containing a distinctive void separating the core material from the shell, constitute promising launch platforms for many biomedical applications. Current hybrid NP systems tend to concentrate on adding extra properties by increasing the number of modules and therefore, system complexity. However, added complexity in itself does not guarantee higher effectiveness. Therefore, in this thesis, a more holistic approach is proposed whereby simplicity, efficiency and usefulness of the design are not overlooked. The work presented here describes a gold-silica rattle-type particle, the Quantum Rattle (QR), made of a hollow mesoporous silica shell (HS) hosting two classes of hydrophobic gold nanostructures: gold quantum dots (AuQDs) and gold nanoparticles (AuNPs). The HS stabilises the gold nanostructures, making them dispersible in water and thereby enables biomedical applications. It also allows passive targeting for the QR via the enhanced permeability and retention (EPR) effect. The AuQDs absorb and emit light in the near-infrared (NIR) biological window where blood and soft tissue are relatively transparent (650 nm - 900 nm). With their NIR photonics, the AuQDs mediate both photothermal therapy (PPT) and live infrared imaging. Finally, the hydrophobic AuNPs optimise the system’s drug carrying performance by increasing the payload’s loading efficiency as well as controlling its release profile. This thesis exhibits the first evidence of the intrinsic and efficient therapeutic and diagnostic potential of this new class of hybrid NP system and discusses how these results could have a significant impact on the growing field of nanosystems used for cancer treatment.
Style APA, Harvard, Vancouver, ISO itp.

Książki na temat "Diagnosis/Therapy"

1

1947-, Stillman RichardM, red. Surgery: Diagnosis & therapy. London: Prentice-Hall International, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Weissleder, Horst. Lymphedema: Diagnosis and therapy. Wyd. 2. Bonn: Kagerer Kommunikation, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

1937-, Stein Jay H., red. Internal medicine: Diagnosis & therapy. Wyd. 3. Norwalk, Conn: Appleton & Lange, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Lymphedema: Diagnosis and therapy. Wyd. 3. Köln: Viavital Verlag, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bertha, Frisch, i SpringerLink (Online service), red. Osteoporosis: Diagnosis, Prevention, Therapy. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Fetal diagnosis and therapy. Philadelphia, PA: Saunders, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Gabriel, Khanm M. I., red. Medical diagnosis and therapy. Philadelphia: Lea & Febiger, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

El, Aad van der. Orthopedic manual therapy diagnosis. Sudbury, Mass: Jones and Bartlett, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ricci, Giano. Periodontal diagnosis and therapy. Milan: Quintessenza Edizioni, 2014.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Albert, Reece E., red. Fetal diagnosis and therapy. Philadelphia: Saunders, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Diagnosis/Therapy"

1

Brockhausen, Inka, i William Kuhns. "Diagnosis and Therapy". W Glycoproteins and Human Disease, 227–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-662-21960-7_27.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Simon, Hermann. "Diagnosis and Therapy". W True Profit!, 93–122. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-76702-0_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Hoyt, Michael F., i Flavio Cannistrà. "Diagnosis and Brief Therapy". W Brief Therapy Conversations, 28–51. New York: Routledge, 2022. http://dx.doi.org/10.4324/9781003307709-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Müller, Günter. "Personalized Diagnosis and Therapy". W Drug Discovery and Evaluation: Pharmacological Assays, 3167–284. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-05392-9_152.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lee, Thomas F. "Disease, Diagnosis, and Therapy". W The Human Genome Project, 183–207. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-6022-1_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Müller, Günter. "Personalized Diagnosis and Therapy". W Drug Discovery and Evaluation: Pharmacological Assays, 1–127. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27728-3_152-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pape, Haiko, i Yu-Mi Ryang. "Osteoporosis (Etiology, Diagnosis, Drug Therapy, Surgical Therapy)". W Spine Surgery, 369–75. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-98875-7_45.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Priest, Jacob B. "Systemic Diagnosis in the Therapy Room". W Systemic Diagnosis, 169–76. New York: Routledge, 2023. http://dx.doi.org/10.4324/9781003295907-13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Jacob, Sharon E., Elise M. Herro i James S. Taylor. "Contact Dermatitis: Diagnosis and Therapy". W Textbook of Clinical Pediatrics, 1467–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_144.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Bothe, Hans-Werner. "Facial Pain: Diagnosis and Therapy". W Samii's Essentials in Neurosurgery, 483–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54115-5_38.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Diagnosis/Therapy"

1

de la Fuente, Jesus M. "Nanoactuators for Therapy and Diagnosis". W Advanced materials and devices for nanomedicine. València: Fundació Scito, 2022. http://dx.doi.org/10.29363/nanoge.amamed.2022.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Subiel, Anna, Carlos Granja i Claude Leroy. "Photodynamic Diagnosis and Therapy of Cancer". W NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295649.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chernov, V., R. Zeltchan, A. Medvedeva, I. Sinilkin i O. Bragina. "Nuclear medicine in cancer diagnosis and therapy". W PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001593.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Shtam, T., R. Samsonov, R. Kamyshinsky, R. Pantina, N. Verlov, A. Vasiliev, A. L. Konevega i A. V. Malek. "Exosomes: Some approaches to cancer diagnosis and therapy". W PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001645.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lin, Alex W. H., Christopher H. Loo, Leon R. Hirsch, Jennifer K. Barton, Min-Ho Lee, Naomi J. Halas, Jennifer L. West i Rebekah A. Drezek. "Nanoshells for integrated diagnosis and therapy of cancer". W Optics East, redaktorzy M. Saif Islam i Achyut K. Dutta. SPIE, 2004. http://dx.doi.org/10.1117/12.570267.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

CZYŻEWSKI, A., i J. KLEJSA. "TINNITUS DIAGNOSIS AND THERAPY METHOD EMPLOYING ULTRASOUND DITHERING". W Proceedings of the Seventh International Workshop. WORLD SCIENTIFIC, 2006. http://dx.doi.org/10.1142/9789812773197_0028.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Zabaneh, SI, J. Kim, G. Pierchalla, U. Schneider, K. Stölzel i S. Dommerich. "Therapy-resistant otitis media – a rare differential diagnosis". W Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1686554.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Sarkodie-Gyan, Thompson. "Optimization of diagnosis and therapy in human gait". W the Community (ICORR). IEEE, 2009. http://dx.doi.org/10.1109/icorr.2009.5209490.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sridhar, S., M. Amiji, D. Shenoy, D. Nagesha, V. Weissig i W. Fu. "Nanomedicine: a new paradigm in diagnosis and therapy". W Optics East 2005, redaktorzy M. Saif Islam i Achyut K. Dutta. SPIE, 2005. http://dx.doi.org/10.1117/12.634259.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Haritha, K., Bethanney Janney J, M. Hemalatha, T. Sudhakar, J. Premkumar i Aishvariya Shivani S. "Varicose Vein Diagnosis System and Therapy: A Review". W 2022 International Conference on Computer, Power and Communications (ICCPC). IEEE, 2022. http://dx.doi.org/10.1109/iccpc55978.2022.10072209.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Diagnosis/Therapy"

1

Zhang, Hui. Use p27KIP1 Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2001. http://dx.doi.org/10.21236/ada396607.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Zhang, Hui. Use P27KIP1 Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2002. http://dx.doi.org/10.21236/ada412764.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Steven Larson MD. Cyclotron Produced Radionuclides for Diagnosis and Therapy of Human Neoplasms. Office of Scientific and Technical Information (OSTI), wrzesień 2009. http://dx.doi.org/10.2172/964282.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Zhang, Hui. Use p27(KIPI) Degradation for Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2003. http://dx.doi.org/10.21236/ada425186.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ingber, Donald. Development of New Approaches for Breast Cancer Therapy and Diagnosis Based on Angiogenesis. Fort Belvoir, VA: Defense Technical Information Center, październik 1996. http://dx.doi.org/10.21236/ada323555.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, październik 2014. http://dx.doi.org/10.21236/ada613187.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, październik 2012. http://dx.doi.org/10.21236/ada568802.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Wang, Paul C. A Partnership Training Program: Studying Targeted Drug Delivery Using Nanoparticles in Breast Cancer Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, październik 2013. http://dx.doi.org/10.21236/ada597692.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Green, Jeffrey E., i Kristin K. Deeb. Cross Species Identification and Functional Analysis of MicroRNAs in Mammary Tumorigenesis: Potential Targets for Detection, Diagnosis and Therapy. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2007. http://dx.doi.org/10.21236/ada473885.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zhenni, Mu, Le Lei, Shen Sinan i Tang Li. Effectiveness of integrated Chinese herbal medicine Shoutai Pill and Western medicine in the treatment of recurrent pregnancy loss: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2021. http://dx.doi.org/10.37766/inplasy2021.10.0062.

Pełny tekst źródła
Streszczenie:
Review question / Objective: We provide a protocol to evaluate the efficacy of integrated Shoutai Pill and Western medicine to update the evaluation for the best available and security treatment for recurrent pregnancy loss(RPL). Condition being studied: Recurrent pregnancy loss (RPL) is a distinct disorder defined by two or more consecutive pregnancy failures before 20 gestational weeks infertile couples. The incidence of this disease accounts for about 1%-5% of women of reproductive age and seriously affects their physical and psychological health. At present, the known etiology of this disease mainly includes abnormal anatomic structures, genetic abnormality, endocrine disorders, prethrombotic status, abnormal immune function, infection, etc. Excluding the above factors, approximately 40-50% of RPL remain unexplained, known as unexplained recurrent pregnancy loss (URPL). At present, the main therapeutic methods of RPL are surgical therapy, preimplantation genetic diagnosis (PGD), hormone therapy, anti-infection therapy, anticoagulation, and immunoregulatory therapy, etc. However, there is no effective treatment has been identified for URPL. Therefore, we still need to investigate effective treatments to reduce pregnancy losses and maintain successful pregnancy preservation in these patients.
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii